Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive
ANT2681
NDM
carbapenem-resistant Enterobacterales
Journal
Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061
Informations de publication
Date de publication:
18 05 2021
18 05 2021
Historique:
received:
06
02
2021
accepted:
30
03
2021
pubmed:
7
4
2021
medline:
22
6
2021
entrez:
6
4
2021
Statut:
epublish
Résumé
The global dissemination of metallo-β-lactamase (MBL)-producing carbapenem-resistant
Identifiants
pubmed: 33820763
pii: AAC.00203-21
doi: 10.1128/AAC.00203-21
pmc: PMC8315971
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Borinic Acids
0
Carboxylic Acids
0
beta-Lactamase Inhibitors
0
taniborbactam
8IGQ156Z07
beta-Lactamases
EC 3.5.2.6
Meropenem
FV9J3JU8B1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2021 Zalacain et al.
Références
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
Genome Med. 2020 Jan 20;12(1):10
pubmed: 31955713
Expert Rev Anti Infect Ther. 2020 Jul;18(7):643-655
pubmed: 32297801
J Med Chem. 2020 Mar 12;63(5):1859-1881
pubmed: 31663735
Curr Opin Microbiol. 2011 Oct;14(5):550-5
pubmed: 21840248
ACS Infect Dis. 2020 Sep 11;6(9):2419-2430
pubmed: 32786279
Am J Orthod Dentofacial Orthop. 2016 Dec;150(6):1066-1067
pubmed: 27894529
J Mol Biol. 2019 Aug 23;431(18):3472-3500
pubmed: 30959050
Antimicrob Agents Chemother. 2020 Nov 17;64(12):
pubmed: 32988825
Expert Opin Pharmacother. 2019 Dec;20(17):2169-2184
pubmed: 31500471
J Antimicrob Chemother. 2015 May;70(5):1420-8
pubmed: 25634992
Clin Infect Dis. 2021 Jun 1;72(11):1871-1878
pubmed: 32427286
Diagn Microbiol Infect Dis. 2010 Nov;68(3):251-8
pubmed: 20851549
J Antimicrob Chemother. 2019 Apr 1;74(4):953-960
pubmed: 30590470
J Antimicrob Chemother. 2020 Dec 1;75(12):3563-3567
pubmed: 32772098
Antimicrob Agents Chemother. 2020 Oct 20;64(11):
pubmed: 32778549
Curr Infect Dis Rep. 2018 May 5;20(6):13
pubmed: 29730830
Infect Genet Evol. 2018 Jul;61:185-188
pubmed: 29626676
J Med Chem. 2015 May 14;58(9):3682-92
pubmed: 25782055
Drug Resist Updat. 2018 Jan;36:13-29
pubmed: 29499835
Antimicrob Agents Chemother. 2020 Sep 21;64(10):
pubmed: 32690645
Antimicrob Agents Chemother. 2001 Apr;45(4):1151-61
pubmed: 11257029
Clin Microbiol Infect. 2000 Sep;6(9):460-3
pubmed: 11168179
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28630191
Diagn Microbiol Infect Dis. 2015 Jul;82(3):209-14
pubmed: 25956930
J Antimicrob Chemother. 2017 Jun 1;72(6):1696-1703
pubmed: 28333332
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S23-S33
pubmed: 30895212
Appl Environ Microbiol. 2018 Aug 31;84(18):
pubmed: 30006399
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29760136
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28167541
Front Mol Biosci. 2018 Feb 23;5:16
pubmed: 29527530
Biomed Res Int. 2014;2014:249856
pubmed: 24790993
Antimicrob Agents Chemother. 2009 Dec;53(12):5046-54
pubmed: 19770275
J Antimicrob Chemother. 2016 Oct;71(10):2704-12
pubmed: 27334663
Antimicrob Agents Chemother. 2020 Oct 20;64(11):
pubmed: 32868334
Antimicrob Agents Chemother. 2017 Jul 25;61(8):
pubmed: 28559260
J Clin Pharmacol. 2003 Oct;43(10):1116-23
pubmed: 14517194